Skip to content

GEERNAERT KOEN

Active Private limited companyfounded 1998active for 28 yearsHoutemstraat 449, 3300 TienenKBO/BCE: BE 0463.208.454

Lifetime

19 annual accounts with figures on one time axis, 27 filings since 1998
peak of €129,488 in 2025
€129,488▲ 20.1%
lowest -€134,423 in 2011
€67,622▲ 33.0%
peak of €425,246 in 2006
€414,303▲ 19.2%
€18,944▼ 81.5%
Board1 name since 2018
1 director
Documentsfilings and deeds
30-03-2026123 days before the deadline
2025micro format
Gross margin from €107,856 to €129,488Result from €50,843 to €67,622 appointed as statutory director 11-04Dividend €833Equity from €347,514 to €414,303Debts from €102,352 to €18,944

Key points

from the 2025 annual accounts

Liquidity

22.70 was 4.02 in 2024

Short-term debts fell from €101,081 to €17,813.

Filings

27 annual accounts since 1998
AprilJune31 JulyOctober200020102020

The last five annual accounts were filed 23 to 127 days before the end of the period.

Position in the sector

95.6%

Higher solvency than 92% of companies in human health. The sector median is 63.1%, over 21,373 companies.

Checked score

Bankruptcy probability within 12 months

Financial strength

Score breakdown

Comparable companies, two years later

In July 2024, 31,390 companies had the same profile as GEERNAERT KOEN has now. Each dot stands for 79 companies, two years later.

93.4%
were still trading
6.0%
stopped another way
0.5%
went bankrupt
  • Micro
  • 20 years or older
  • solvency 30% or more
  • a profit of 5% of the balance sheet or more

Another 0.1% stopped without a precise date, possibly only after those two years.

Test of the method

The method was tested on the 497,994 companies of July 2024. Each company was given the bankruptcy share of the same profile a year earlier, in July 2023. The expectation was that 1.6% would go bankrupt within 24 months. In fact 1.7% went bankrupt.

The companies in ten equal groups, from the lowest to the highest expected share
Group Expected Actual
1 0.2% 0.2%
2 0.3% 0.5%
3 0.5% 0.6%
4 0.7% 0.8%
5 0.9% 0.9%
6 1.3% 1.5%
7 1.6% 1.8%
8 1.8% 1.8%
9 2.9% 3.1%
10 5.6% 6.1%

A company that went bankrupt had a higher expected share than one that kept going in 74.5% of comparisons. The level depends on the economy. In a year with more bankruptcies than the year before, the actual share is higher than the expected one.

This is an observation about 31,390 companies, not a prediction for GEERNAERT KOEN. The sector does not count, because the KBO no longer lists a sector for a company that has stopped. By sector, mostly the survivors would count, which would paint too rosy a picture.

Credit verdict

Credit check for an amount and term of your choice

Show the recommended maximum and see how the verdict changes with amount, term and advance.

The scores and ratios are Checked's own calculations, not a credit decision.

Signals

Board and ownership

Director
Board & ownership

Recent changes

appointed as statutory director Legal-form conversion: from private limited company (pre-2019) to private limited company · General meeting of 04-04-2025 · Gazette deed
reappointed as manager General meeting of 18-03-2019 · Gazette deed
Capital increase of €100,685.47 to €119,277.48 The capital rose from €18,592.01 to €119,277.48, with 301 new shares · General meeting of 30-01-2014 · Gazette deed
First establishment Houtemstraat 449, Tienen
All 40 events

Comparable companies

same main activity, similar in size and age
Company
GEERNAERT KOEN Tienen €433,247 €129,488 95.6% -
Dokter Xavier Martens Hasselt €420,964 €129,428 86.4% -
PROFESSEUR GALAND OPHTALMOLOGIE Neupré €435,968 €135,378 89.3% -
KERKHOFS-JANSSENS Rumes €430,435 €140,582 38.1% -
DR. LISSENS MARK Geel €424,622 €141,569 63.0% -
Corso Mons €464,589 €121,276 98.3% -
Dokter Geert Veeckman Sint-Martens-Latem €385,155 €124,628 4.1% -

These companies have the same main activity as GEERNAERT KOEN: specialist medical practice (NACE 86220). They are comparable in size and age: total assets between €385,000 and €465,000, founded between 1996 and 1999.

Official details

Source: KBO
Status
Active since 20-04-1998Normal situation
Activity
Specialist medical practiceNACE 86220
Establishment unit
2.286.845.4723300 Tienen, since 19-01-2003
Financial year end
31 December
Peppol
Not found in the Peppol Directory
Company details

Annual accounts 2025

≈ €240,000estimated
€433,247▼ 3.7%
Filing
Filed on 30-03-2026, 123 days before the end of the filing period
Financials

Insights on GEERNAERT KOEN

GEERNAERT KOEN files the micro format. That format states no turnover. The gross margin rose from €122,138 in 2006 to €129,488 in 2025.

Sources: KBO register, filings at the National Bank, Belgian Official Gazette. Click a figure with a dotted line for the item and the filing.

Key facts about GEERNAERT KOEN

What is the company number of GEERNAERT KOEN?
The company number of GEERNAERT KOEN is 0463.208.454. The VAT number is the same number with BE in front: BE 0463.208.454.
Where is GEERNAERT KOEN based?
The registered office is at Houtemstraat 449, 3300 Tienen.Company details
What does GEERNAERT KOEN do?
According to the KBO register, the main activity is specialist medical practice (NACE 86220).
What is the legal form of GEERNAERT KOEN?
GEERNAERT KOEN is a private limited company (BV).
When was GEERNAERT KOEN founded?
GEERNAERT KOEN was founded on 20-04-1998.
Is GEERNAERT KOEN still active?
Yes, GEERNAERT KOEN is an active enterprise in the KBO register.
What is the turnover of GEERNAERT KOEN?
The turnover in financial year 2025 is about €240,000. This figure is estimated from the gross margin of €129,488 and 40 comparable companies (NACE 86220). It probably lies between €200,000 and €320,000.Financials
Is GEERNAERT KOEN profitable?
In financial year 2025, GEERNAERT KOEN made a profit of €67,622.
Where can I find the annual accounts of GEERNAERT KOEN?
GEERNAERT KOEN filed 27 annual accounts with the National Bank of Belgium, the latest for financial year 2025.
When are the next annual accounts of GEERNAERT KOEN due?
GEERNAERT KOEN must file the annual accounts for financial year 2026 by 31-07-2027.Timeline

Next steps

See how customers, suppliers and banks see your own company and what to improve first.

Keep this company with today's facts in a case file.